Antibody Drug Conjugate (ADC) Contract Manufacturing
Product
Information
Delivering confidence in every conjugate In the rapidly advancing field of ADC's, timing and precision are critical. With Pfizer's deep scientific and operational expertise, you gain a trusted partner to accelerate delivery of your ADC therapies — bringing transformative treatments to patients when they need them most. Experts at the forefront of ADC progression: Experts with advanced degrees and extensive ADC manufacturing experience A wealth of experience in development and scale-up of antibody and protein technologies Decades of combined experience in mammalian cell culture and single-use ADC conjugation A track record of outstanding safety performance and on-time deliveryResponsible for the world's first commercially approved ADC product (MylotargTM)
Distribution Areas
OceaniaNorth America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied From
United States
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)
All Categories
Contract ManufacturingCustom Manufacturing (general category)Antibody Drug Conjugates (ADCs)
